NCT07192263: Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
- State
- Not started
- Phase
- Phase 3
- People
- 300 planned
- Started
- 22 Sep 2025
- Primary completion
- 31 Dec 2026
- Arms
- IN-B00009
- Results
- None posted
- 25 Sep 2025: Trial registered